CIPLA LTD. - 500087 - Notice Of Postal Ballot
In compliance with regulation 30 of Listing Regulations, we had submitted the Notice of Postal Ballot dated 11th April 2024 on 16th April 2024 with the BSE. We noted that due to technical reasons, the said intimation is not visible on the BSE website. As per advise from BSE, we are re-submitting the said intimation. We request you to please take the above intimation on record in compliance with the Listing Regulations requirements. CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find the attached newspaper publication. CIPLA LTD. - 500087 - Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
Compliance certificate under Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 CIPLA LTD. - 500087 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories Participant) Regulations, 2018 CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
In compliance with the provisions of Regulation 30 (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby notify that the Operations and Administrative Committee of the Company on 15th April 2024 has allotted 27,906 fully paid-up equity shares of INR 2 each, pursuant to exercise of ESOPs under the Employee Stock Option Scheme 2013-A of the Company. Consequently, the issued, subscribed and paid-up Capital of the Company stands increased to INR 1,61,47,89,936 comprising of 80,73,94,968 equity shares of face value INR 2 each.
Cipla's India arm inks business transfer agreement with Ivia Beaute; shares trade flat
Cipla Share Price: A meeting of the board of directors of the company will be held on May 10, 2024, to consider and approve the standalone and consolidated audited financial results. CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Acquisition
Acquisition of a business undertaking from Ivia Beaute Private Limited, India CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Earnings Conference Call to be held on 10th May 2024. CIPLA LTD. - 500087 - Board Meeting Intimation for Quarter And Year Ended 31St March 2024 Under SEBI Listing Regulations
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 ,inter alia, to consider and approve 1. Consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended 31st March 2024. 2. Recommend final dividend for the year ended 31st March 2024, if any. In terms of the Company's Code of Conduct for Prevention of Insider Trading, the 'Trading Window' for dealing in the securities of the Company is closed from Monday, 1st April 2024 till Sunday, 12th May 2024 (both days inclusive) for the purpose of financial results.
US FDA's 6 observations for Cipla's Patalganga unit drags firm's shares down 1.5%
Cipla's Patalganga plant manufactures active pharmaceutical ingredients (APIs), the key raw materials for medicines, as well as formulations.